Literature DB >> 15500870

Brain atrophy, interferon beta, and treatment trials in multiple sclerosis.

David H Miller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500870     DOI: 10.1016/S0140-6736(04)17285-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis.

Authors:  Philipp Albrecht; Ruth Fröhlich; Hans-Peter Hartung; Bernd C Kieseier; Axel Methner
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

2.  Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.

Authors:  Claire Meyniel; Timothy Spelman; Vilija G Jokubaitis; Maria Trojano; Guillermo Izquierdo; François Grand'Maison; Celia Oreja-Guevara; Cavit Boz; Alessandra Lugaresi; Marc Girard; Pierre Grammond; Gerardo Iuliano; Marcela Fiol; Jose Antonio Cabrera-Gomez; Ricardo Fernandez-Bolanos; Giorgio Giuliani; Jeannette Lechner-Scott; Edgardo Cristiano; Joseph Herbert; Tatjana Petkovska-Boskova; Roberto Bergamaschi; Vincent van Pesch; Fraser Moore; Norbert Vella; Mark Slee; Vetere Santiago; Michael Barnett; Eva Havrdova; Carolyn Young; Carmen-Adella Sirbu; Mary Tanner; Michelle Rutherford; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.